Thirteen years of work by two leaders in Binghamton University's School of Pharmacy produced a drug designed to ease the symptoms of Duchenne muscular dystrophy while being free of commonly seen side ...

More information about Darius' story and clinical trial. Nov. 22, 2012— -- "Nightline" profiled Darius Weems, a 23-year-old aspiring rapper who suffers from Duchenne Muscular Dystrophy, a rare ...

Duchenne muscular dystrophy (DMD) is a rare neurological condition that causes severe muscle weakness and intellectual disability. DMD is an inherited (passed down) disorder. The condition is linked ...

Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration and weakness due to the alterations of a protein called dystrophin that helps keep muscle cells ...

A new study led by researchers at Hospital for Special Surgery (HSS) suggests that currently available therapies may help control chronic muscle inflammation in Duchenne muscular dystrophy (DMD), a ...

Riley Moser is a digital producer who covers breaking news and feature stories for CBS Minnesota. Riley started her career at CBS Minnesota in June 2022 and earned an honorable mention for sports ...

Multiparametric qMRI effectively differentiates between DMD and BMD in ambulatory children, especially under 10 years old with mild symptoms. Fat fraction (FF) is the preferred qMRI biomarker for ...

Caregivers of patients with Duchenne muscular dystrophy (DMD) experience notable work productivity loss, with high absenteeism and presenteeism rates, impacting their personal lives. Adult caregivers ...

NASHVILLE, Tenn., March 19, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company with development efforts focused on rare diseases, today announced ...

The FDA approved Duvyzat (givinostat), a novel histone deacetylase (HDAC), for the treatment of patients six years of age and older with Duchenne muscular dystrophy (DMD). This approval marks an ...

In a new study published in The FASEB Journal, investigators demonstrated the potential of a molecule that may help overcome some of the devastating symptoms of Duchenne muscular dystrophy (DMD), the ...